Newcells Biotech secures over £5m for 3D tissue models
Newcells Biotech have received multi-million investment to develop their pioneering 3D tissue models
Newcastle-based human stem cell model specialists,Newcells Biotech
, have secured a total of £5.25m worth of funding to accelerate their growth plans in the international life sciences market.
The funding comes from two existing backers. Mercia has invested from its Northern Venture Capital Trust (VCT) and Enterprise Investment Scheme (EIS) funds and the North East Venture Fund (NEVF), which is supported by the European Regional Development Fund (ERDF); while NorthStar Ventures invested from the North East Innovation Fund, which is also supported by the ERDF. This funding round will help Newcells Biotech expand their growth in 3D tissue modelling for drug discovery.
A comprehensive 360-degree view of financial advice underpins PA360 Conference. With an unmissable line-up of dynamic speakers ranged across three streams focusing on what matters most to advisers PA360 will inform, educate and inspire, allowing delegates to meet new service providers and professional partners, and provide invaluable networking opportunities.
Date: 07 Oct 2021